The Latin America, Middle East and Africa Precision Diagnostics Market is projected to witness market growth of 20.9% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Precision Diagnostics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $1.01 billion by 2031. The Argentina market is registering a CAGR of 21.6% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 19.8% during (2024 - 2031).
Precision diagnostics aid in diagnosing, monitoring, and personalized managing autoimmune diseases and immune deficiencies. They detect specific autoantibodies (such as ANA and anti-dsDNA) to diagnose conditions like lupus and rheumatoid arthritis.
Additionally, they analyze immune cell subsets, cytokines, and inflammatory markers to characterize immune responses and assess disease activity. Multiplex assays for profiling immune biomarkers in autoimmune diseases and predicting treatment responses.
The prevalence of non-communicable diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders is rising in Saudi Arabia. This demographic shift towards chronic conditions necessitates accurate and early diagnosis to effectively manage these diseases. According to the International Trade Administration (ITA), non-communicable diseases account for 68 percent of all deaths in Saudi Arabia. Almost 18 percent of the adult population has diabetes, and more than 40 percent are obese.
The Brazil market dominated the LAMEA Precision Diagnostics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $1.01 billion by 2031. The Argentina market is registering a CAGR of 21.6% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 19.8% during (2024 - 2031).
Precision diagnostics aid in diagnosing, monitoring, and personalized managing autoimmune diseases and immune deficiencies. They detect specific autoantibodies (such as ANA and anti-dsDNA) to diagnose conditions like lupus and rheumatoid arthritis.
Additionally, they analyze immune cell subsets, cytokines, and inflammatory markers to characterize immune responses and assess disease activity. Multiplex assays for profiling immune biomarkers in autoimmune diseases and predicting treatment responses.
The prevalence of non-communicable diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders is rising in Saudi Arabia. This demographic shift towards chronic conditions necessitates accurate and early diagnosis to effectively manage these diseases. According to the International Trade Administration (ITA), non-communicable diseases account for 68 percent of all deaths in Saudi Arabia. Almost 18 percent of the adult population has diabetes, and more than 40 percent are obese.
List of Key Companies Profiled
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
Market Report Segmentation
By End-use- Clinical Laboratories
- Hospitals
- Others
- Genetic Tests
- Esoteric Tests
- Direct to Consumer Tests
- Others
- Oncology
- Respiratory Diseases
- CNS Disorders
- Immunology
- Skin Diseases
- Genetic Diseases
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Precision Diagnostics Market by End-use
Chapter 6. LAMEA Precision Diagnostics Market by Type
Chapter 7. LAMEA Precision Diagnostics Market by Application
Chapter 8. LAMEA Precision Diagnostics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
Methodology
LOADING...
